US drugmaker Eli Lilly and Company announced that it was slashing prices of its most commonly-prescribed insulins by 70 percent. Lilly said it would cut the price of its non-branded insulin to $25 a vial from May 1. It will also cut the price of Humalog, the company’s most commonly-prescribed insulin and Humalin injections by 70 percent towards the end of the year.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Two-day pharma and healthcare expo kickstarts

Lahore: Pak Pharma and Healthcare expo in collaboration with the Pakistan Pharmaceutical…

Punjab changes admission policy for medical, dental colleges

The Punjab education authorities have changed the admission policy for the government…

Trio wins Nobel Chemistry Prize for quantum dots

French-born Moungi Bawendi, Louis Brus of the United States and Russian-born Alexei…

Pakistan records 150 fresh Covid-19 cases

Pakistan has registered one death in the last 24 hours by Covid-19,…